Androgenetic Alopecia Overview
AGA, also known as hair loss, is frequently referred to as "Male Pattern Baldness" or "Female Pattern Baldness."Hair loss affects the patient's mental health greatly and is a topic of great public attention. To have a positive impact on the patients' quality of life, comprehensive understanding of the pathogenesis and treatment options for the various kinds of alopecia is essential.
Androgenetic Alopecia market size is expected to grow with a significant CAGR during the study period (2019-2032).
Androgenetic Alopecia Epidemiology Segmentation in the 7MM from 2019 to 2032
- Prevalent Cases
- Gender-specific Prevalence
- Age-specific Prevalence
- Risk Factor Prevalent Cases
- Diagnosed and Treatable Cases
Androgenetic Alopecia Emerging Drugs and key Companies
- Clascoterone solution: Cassiopea, Inc.
- FOL-005: Follicum AB, and others